Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Radiographics ; 43(8): e230032, 2023 08.
Article in English | MEDLINE | ID: mdl-37498784

ABSTRACT

Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are two common disorders that affect the anterior compartment of the pelvic floor in women. These can be treated conservatively or surgically. Among patients treated surgically, a substantial number present with pain, recurrent POP or SUI, or other conditions that warrant additional interventions. In many of these cases, imaging is key to identifying and characterizing the type of procedure performed, locating synthetic materials that may have been placed, and characterizing complications. Imaging may be particularly helpful when prior surgical records are not available or a comprehensive physical examination is not possible. US and MRI are the most commonly used modalities for such patients, although radiopaque surgical materials may be visible at voiding cystourethrography and CT. The authors summarize commonly used surgical treatment options for patients with SUI and POP, review imaging techniques for evaluation of such patients, and describe the normal imaging appearance and complications of pelvic floor surgical repair procedures in the anterior compartment of the pelvis. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.


Subject(s)
Pelvic Organ Prolapse , Plastic Surgery Procedures , Urinary Incontinence, Stress , Humans , Female , Pelvic Floor/diagnostic imaging , Pelvic Floor/surgery , Pelvic Organ Prolapse/diagnostic imaging , Pelvic Organ Prolapse/surgery , Urinary Incontinence, Stress/diagnostic imaging , Urinary Incontinence, Stress/surgery , Urinary Incontinence, Stress/complications , Multimodal Imaging
2.
Hepatol Commun ; 7(7)2023 07 01.
Article in English | MEDLINE | ID: mdl-37314737

ABSTRACT

BACKGROUND AIMS: Early-stage HCC can be treated with thermal ablation or stereotactic body radiation therapy (SBRT). We retrospectively compared local progression, mortality, and toxicity among patients with HCC treated with ablation or SBRT in a multicenter, US cohort. APPROACH RESULTS: We included adult patients with treatment-naïve HCC lesions without vascular invasion treated with thermal ablation or SBRT per individual physician or institutional preference from January 2012 to December 2018. Outcomes included local progression after a 3-month landmark period assessed at the lesion level and overall survival at the patient level. Inverse probability of treatment weighting was used to account for imbalances in treatment groups. The Cox proportional hazard modeling was used to compare progression and overall survival, and logistic regression was used for toxicity. There were 642 patients with 786 lesions (median size: 2.1 cm) treated with ablation or SBRT. In adjusted analyses, SBRT was associated with a reduced risk of local progression compared to ablation (aHR 0.30, 95% CI: 0.15-0.60). However, SBRT-treated patients had an increased risk of liver dysfunction at 3 months (absolute difference 5.5%, aOR 2.31, 95% CI: 1.13-4.73) and death (aHR 2.04, 95% CI: 1.44-2.88, p < 0.0001). CONCLUSIONS: In this multicenter study of patients with HCC, SBRT was associated with a lower risk of local progression compared to thermal ablation but higher all-cause mortality. Survival differences may be attributable to residual confounding, patient selection, or downstream treatments. These retrospective real-world data help guide treatment decisions while demonstrating the need for a prospective clinical trial.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Radiosurgery , Adult , Humans , Carcinoma, Hepatocellular/radiotherapy , Retrospective Studies , Radiosurgery/adverse effects , Liver Neoplasms/radiotherapy , Patient Selection
3.
Radiol Clin North Am ; 61(4): 639-649, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37169429

ABSTRACT

Cervical cancer remains a significant contributor to morbidity and mortality for women globally despite medical advances in preventative medicine and treatment. The 2018 Internal Federation of Gynecology and Obstetrics committee modified their original 2009 staging scheme to incorporate advanced imaging modalities, where available, to increase the accuracy of staging and to guide evolving treatments. Having a robust understanding of the newest staging iteration, its consequences on treatment pathways, and common imaging pitfalls will aid the radiologist in generating valuable and practical reports to optimize treatment strategies.


Subject(s)
Gynecology , Obstetrics , Uterine Cervical Neoplasms , Female , Humans , Uterine Cervical Neoplasms/diagnostic imaging , Uterine Cervical Neoplasms/therapy , Uterine Cervical Neoplasms/pathology , Neoplasm Staging , Magnetic Resonance Imaging/methods
4.
Case Rep Obstet Gynecol ; 2022: 7624305, 2022.
Article in English | MEDLINE | ID: mdl-35814167

ABSTRACT

We report a case of stage IVB ovarian clear cell carcinoma in a 35-year-old female with a long-standing history of biopsy-proven pelvic and thoracic endometriosis. At the time of her ovarian cancer diagnosis, her tumors were found to be isolated to the sites of her previously known endometriotic lesions, suggesting that malignant transformation of her endometriosis to ovarian cancer had occurred. She underwent primary tumor debulking, then received six cycles of intravenous carboplatin and paclitaxel, and is now free of disease. We have conducted a literature review of ovarian cancers arising from endometriosis as well as a summary of the molecular basis on the relationship between endometriosis and malignant ovarian carcinoma.

5.
J Vasc Surg ; 59(6): 1644-50, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24560864

ABSTRACT

OBJECTIVE: Patients with occlusive or aneurysmal vascular disease are repeatedly exposed to intravascular (IV) contrast for diagnostic or therapeutic purposes. We sought to determine the long-term impact of cumulative iodinated IV contrast exposure (CIVCE) on renal function; the latter was defined by means of National Kidney Foundation (NKF) criteria. METHODS: We performed a longitudinal study of consecutive patients without renal insufficiency at baseline (NFK stage I or II) who underwent interventions for arterial occlusive or aneurysmal disease. We collected detailed data on any IV iodinated contrast exposure (including diagnostic or therapeutic angiography, cardiac catheterization, IV pyelography, computed tomography with IV contrast, computed tomographic angiography); medication exposure throughout the observation period; comorbidities; and demographics. The primary end point was the development of renal failure (RF) (defined as NFK stage 4 or 5). Analysis was performed with the use of a shared frailty model with clustering at the patient level. RESULTS: Patients (n = 1274) had a mean follow-up of 5.8 (range, 2.2-14) years. In the multivariate model with RF as the dependent variable and after adjusting for the statistically significant covariates of baseline renal function (hazard ratio [HR], 0.95; P < .001), diabetes (HR, 1.8; P = .007), use of an angiotensin-converting enzyme inhibitor (HR, 0.63; P = .03), use of antiplatelets (HR, 0.5; P = .01), cumulative number of open vascular operations performed (HR, 1.2; P = .001), and congestive heart failure (HR, 3.2; P < .001), CIVCE remained an independent predictor for RF development (HR, 1.1; P < .001). In the multivariate survival analysis model and after adjusting for the statistically significant covariates of perioperative myocardial infarction (HR, 3.9; P < .001), age at entry in the cohort (HR, 1.05; P = .035), total number of open operations (HR, 1.51; P < .001), and serum albumin (HR, 0.47; P < .001), CIVCE was an independent predictor of death (HR, 1.07; P < .001). CONCLUSIONS: Cumulative IV contrast exposure is an independent predictor of RF and death in patients with occlusive and aneurysmal vascular disease.


Subject(s)
Aneurysm/diagnostic imaging , Angiography/adverse effects , Arterial Occlusive Diseases/diagnostic imaging , Contrast Media/adverse effects , Glomerular Filtration Rate/drug effects , Renal Insufficiency/chemically induced , Risk Assessment/methods , Adult , Aged , Aged, 80 and over , Contrast Media/administration & dosage , Female , Follow-Up Studies , Humans , Injections, Intravenous , Kidney/drug effects , Kidney/physiopathology , Male , Middle Aged , Renal Insufficiency/mortality , Renal Insufficiency/physiopathology , Retrospective Studies , Risk Factors , Survival Rate/trends , Texas/epidemiology , Time Factors
6.
J Vasc Surg ; 57(5): 1331-7; discussion, 2013 May.
Article in English | MEDLINE | ID: mdl-23384496

ABSTRACT

OBJECTIVE: Controversy surrounds the topic of transfusion policy after noncardiac operations. This study assessed the combined impact of postoperative nadir hemoglobin (nHb) levels and blood transfusion on adverse events after open surgical intervention in patients who undergo operative intervention for atherosclerotic vascular disease. METHODS: Consecutive patients who underwent peripheral arterial disease (PAD)-related operations were balanced on baseline characteristics by inverse weighting on propensity score calculated as their probability to have nHb greater than 10 gm/dL on the basis of operation type, demographics, and comorbidities, including the revised cardiac risk index. A multivariate generalized estimating equation analysis was performed to investigate associations between nHb, transfusion, and a composite outcome of perioperative death and myocardial infarction. Logistic and Cox proportional hazards regressions were used to assess the impact of nHb and transfusion on respiratory and wound complications; and a composite end point (CE) of death, myocardial infarction during a 2-year follow-up. Level of statistical significance was set at alpha of 0.0125 to adjust for the increased probability of type I error attributable to multiple comparisons. RESULTS: The analysis cohort included 880 patients (1074 operations). After adjusting for nHb level, the number of units transfused was not associated with the perioperative occurrence of the CE (odds ratio [OR], 1.13; P = .025). Adjusted for the number of units transfused, nHb had no impact on the perioperative CE (OR, 0.62; P = .22). An interaction term between transfusion and nHb level remained nonsignificant (P = .312), indicating that the impact of blood transfusion was the same regardless of the nHb level. Perioperative respiratory complications were more likely in patients receiving transfusions (OR, 1.22; P = .009), and perioperative wound infections were less common in patients with nHb >10 gm/dL (OR, 0.65; P = .01). During an average follow-up of 24 months, transfused patients were more likely to develop the CE (hazard ratio [HR], 1.15, P = .009), whereas nHb level did not impact the long-term adverse event rate (HR, 0.78; P = .373). The above associations persisted even after adjusting the Cox regression model for the occurrence of perioperative cardiac events. CONCLUSIONS: Although nHb less than 10 gm/dL is not associated with death or ACS after PAD-related operations, maintaining nHb greater than 10 gm/dL appears to decrease the risk of wound infection. Blood transfusion is associated with increased risk of perioperative respiratory complications. Until a randomized trial settles this issue definitively, a restrictive transfusion strategy is justified in patients undergoing operations for atherosclerotic vascular disease.


Subject(s)
Blood Transfusion , Hemoglobins/metabolism , Peripheral Arterial Disease/surgery , Postoperative Hemorrhage/therapy , Vascular Surgical Procedures/adverse effects , Acute Coronary Syndrome/etiology , Aged , Biomarkers/blood , Blood Transfusion/mortality , Comorbidity , Humans , Kaplan-Meier Estimate , Logistic Models , Middle Aged , Multivariate Analysis , Myocardial Infarction/etiology , Odds Ratio , Peripheral Arterial Disease/blood , Peripheral Arterial Disease/mortality , Postoperative Hemorrhage/blood , Postoperative Hemorrhage/etiology , Postoperative Hemorrhage/mortality , Propensity Score , Proportional Hazards Models , Respiration Disorders/etiology , Retrospective Studies , Risk Assessment , Risk Factors , Surgical Wound Infection/etiology , Time Factors , Transfusion Reaction , Treatment Outcome , Vascular Surgical Procedures/mortality
7.
J Vasc Surg ; 57(1): 72-6, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23127982

ABSTRACT

INTRODUCTION: Percutaneous endovascular aneurysm repair (PEVAR) has been shown to be feasible; however, technical success is variable, reported to be between 46.2% and 100%. The objective of this study was to quantify the learning curve of the PEVAR closure technique and identify predictors of closure failure. METHODS: We reviewed patient- and procedure-related characteristics in 99 consecutive patients who underwent PEVAR over a 30-month period in a single academic institution. A suture-mediated closure device (Proglide or Prostar XL) was used. Forward stepwise logistic regression was used to investigate associations between the failure of the closure technique and a number of patient and operative characteristics. To ensure objective assessment of the learning curve, a time-dependent covariate measuring time in calendar quarters was introduced in the model. Poisson regression was used to model the trend of observed failure events of the percutaneous technique over time. RESULTS: Overall PEVAR technical success was 82%. Type of closure device (P<.35), patient's body mass index (P<.86), type of anesthesia (P<.95), femoral artery diameter (P<.09), femoral artery calcification (P<.56), and sheath size as measured in Fr (P<.17) did not correlate with closure failure rates. There was a strong trend for a decreasing number of failure events over time (P<.007). The average decrease in the odds of technical failure was 24% per calendar quarter. The predicted probability of closure failure decreased from 45% per patient at the time of the initiation of our PEVAR program to 5% per patient at the end of the 30-month period. There were two postoperative access-related complications that required surgical repair. Need for surgical cutdown in the event of closure failure prolonged the operative time by a mean of 45 minutes (P<.001). No groin infections were seen in the percutaneous group or the failed group. CONCLUSIONS: Technical failure can be reduced as the surgeon gains experience with the suture-mediated closure device utilized during PEVAR. Previous experience with the Proglide device does not seem to influence the learning curve.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Aortic Aneurysm, Thoracic/surgery , Clinical Competence , Endovascular Procedures/adverse effects , Endovascular Procedures/education , Learning Curve , Endovascular Procedures/instrumentation , Humans , Logistic Models , Odds Ratio , Postoperative Complications/etiology , Postoperative Complications/surgery , Reoperation , Retrospective Studies , Risk Assessment , Risk Factors , Suture Techniques/adverse effects , Suture Techniques/education , Texas , Time Factors , Treatment Failure
8.
Mol Biosyst ; 6(9): 1561-4, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20467666

ABSTRACT

Cyclic-di-GMP signaling is used by many bacteria to control biofilm formation. As biofilm formation is an important survival strategy for many bacteria, the synthesis and degradation of cyclic-di-GMP is tightly regulated by enzymes containing domains with conserved GGDEF and EAL sequence motifs, respectively. In this report we characterize a protein with both cyclase and phosphodiesterase activities and demonstrate that it contributes to secretion of the extracellular polysaccharide matrix, an important step in early biofilm formation.


Subject(s)
Bacterial Proteins/metabolism , Phosphoric Diester Hydrolases/metabolism , Phosphorus-Oxygen Lyases/metabolism , Shewanella/enzymology , Bacterial Proteins/genetics , Escherichia coli Proteins , Phosphoric Diester Hydrolases/genetics , Phosphorus-Oxygen Lyases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...